| T2D | Type-2 diabetes; |
| IRFs | Interferon regulatory factors; |
| BMI | Body mass index; |
| HbA1c | Hemoglobin A1c; |
| CRP | C-reactive protein; |
| TNF-α | Tumor necrosis factor-alpha; |
| IL | Interleukin; |
| CXCL | CXC motif ligand; |
| CCL | CC motif ligand; |
| RT-PCR | Reverse-transcription polymerase chain reaction; |
| MGB | Minor groove binder; |
| FAM | 6-fluorescein amidite; |
| NFQ | Non-fluorescent quencher; |
| GAPDH | Glyceraldehyde 3-phosphate dehydrogenase; |
| IHC | Immunohistochemistry; |
| DAB | 3,3ʹ-diaminobenzidine; |
| DAPI | 4’,6-diamidino-2-phenylindole; |
| RANTES | Regulated on activation, normal T-cell expressed and secreted; |
| IRAK-1 | Interleukin-1 receptor-associated kinase-1; |
| MyD88 | Myeloid differentiation primary response 88; |
| ATMs | Adipose tissue macrophages. |